您好,欢迎来到试剂信息网! [登录] [免费注册]
试剂信息网
位置:首页 > 产品库 > (R)-STU104
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
(R)-STU104
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
(R)-STU104图片
CAS NO:2767124-77-4
包装与价格:
包装价格(元)
100mg电议
250mg电议
500mg电议

产品介绍
(R)-STU104 是一种有效且具有口服活性的TAK1MKK3蛋白质互作抑制剂,对TNF-α和 MKK3 磷酸化的IC50分别为 0.58 μM 和 4.0 μM。(R)-STU104 通过与 MKK3 结合,阻断 TAK1 磷酸化 MKK3,抑制 TAK1/MKK3/p38/MnK1/MK2/elF4E 信号通路。(R)-STU104 可用于溃疡性结肠炎的研究。
生物活性

(R)-STU104 is a potent and orally activeTAK1-MKK3 interactioninhibitor withIC50s of 0.58 μM and 4.0 μM forTNF-αand MKK3 phosphorylation. (R)-STU104 suppresses the TAK1/MKK3/p38/MnK1/MK2/elF4E signal pathways through binding with MKK3 and disrupting the TAK1 phosphorylating MKK3. (R)-STU104 can be used for researching ulcerative colitis[1].

IC50& Target

IC50: 0.58 μM (TNF-α), 4.0 μM (MKK3 phosphorylation)[1]

体外研究
(In Vitro)

(R)-STU104 attenuates phosphorylation levels of Mnk1, MK2, and elF4E, leading to the downregulation of TNF-α expression and production[1].

体内研究
(In Vivo)

(R)-STU104 (1, 3 and 10 mg/kg; IG for 7 days) ameliorates the symptoms of DSS-induced experimental colitis in mice, and significantly inhibits inflammatory cytokine protein[1].
Pharmacokinetic Parameters of (R)-STU104 in male C57 mice[1].

IV (5 mg/kg)PO (30 mg/kg)
Tmax(h)0.083
AUC0-t(μg/L·h)72499895
AUC0-∞(μg/L·h)863516991
MRT0-∞(h)7.3212.52
Cmax(ng/mL)29202290
t1/2(ng/mL)9.298.67
VZ(L/kg)7.763.68
CLZ(ng/mL)0.580.29
F (%)33%

Animal Model:C57BL/6 mice (dextran sodium sulfate (DSS)-induced acute ulcerative colitis)[1]
Dosage:1, 3 and 10 mg/kg
Administration:IG, for 7 days
Result:Ameliorated the symptoms of DSS-induced experimental colitis, and significantly inhibited inflammatory cytokine protein TNF-α, IL-1β, IL-6, and IL-23.
分子量

298.33

Formula

C18H18O4

CAS 号

2767124-77-4

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.